,,ii  #aaith ,,congress  #ast ,session  
,s4 #adjg  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,april #aj1    
#bjbe,mr4 ,cotton introduced the        
following bill2 which was read twice and
 referred to the ,committee on ,finance 
,a ,,bill  ,to ban the use of ,federal  
funds for the purchase of drugs         
manufactured in the ,people's ,republic 
of ,china1 and for other purposes4  #a4 
,short title ,this ,act may be cited as 
the ,anyone ,but ,china ,safe ,drug ,act
 or the ,,abc ,safe ,drug ,act4  #b4    
,federal health program purchase of     
drugs  7a7 ,federal health program      
purchase of drugs  7#a7 ,in general     
,notwithstanding any other provision of 
law1 with respect to the purchase of a  
drug by the ,department of ,health and  
,human ,services1 the ,department of    
,veterans ,affairs1 the ,department of  
,defense1 or any other ,federal health  
care program 7as defined in section     
#aabh;,b7f7 of the ,social ,security    
,act 7#db ,u4,s4,c4 #acbj;a-#g;b7b7771  

the following shall apply3 7,a7         
,beginning on ,january #a1 #bjbh1 such  
agency or program may purchase only     
drugs for which #fj percent or more of  
the active pharmaceutical ingredients   
are manufactured in countries described 
in paragraph 7#b74  7,b7 ,beginning on  
,january #a1 #bjcj1 such agency or      
program may purchase only drugs for     
which #ajj percent of the active        
pharmaceutical ingredients are          
manufactured in countries described in  
paragraph 7#b74  7#b7 ,countries        
described ,the countries described in   
this paragraph are countries-- 7,a7     
other than ,people's ,republic of       
,china2 and  7,b7 that meet the health  
and safety standards of the ,food and   
,drug ,administration4  7#c7 ,waivers   
,the ,secretary of ,health and ,human   
,services may issue waivers of the      
requirements under paragraph 7#a7 for   
any agency or program that is unable to 
meet such requirements and demonstrates 
a need for the waiver4 ,no waiver may be

 issued under this paragraph for drugs  
that are purchased on or after ,january 
#a1 #bjca4  7b7 ,labeling requirement   
,section #ejb of the ,federal ,food1    
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #ceb7 is amended by adding at the end  
the following3  7hh7 ,if it is a drug   
and its labeling does not specify the   
country of origin of each active        
ingredient contained in the drug4  4    
#c4 ,temporary #ajj percent expensing   
for pharmaceutical and medical device   
manufacturing property  7a7 ,in ,general
 ,for purposes of section #afh7k7 of the
 ,internal ,revenue ,code of #aihf1 in  
the case of any qualified pharmaceutical
 and medical device manufacturing       
property which is placed in service     
after ,december #ca1 #bjbd1 and before  
,january #a1 #bjca-- 7#a7 such property 
shall be treated as a qualified property
 7within the meaning of such section72  
7#b7 the applicable percentage otherwise
 determined under section #afh7k77#f7 of
 such ,code with respect to such        

property shall be #ajj percent2 and     
7#c7 paragraph 7#h7 of such section     
shall not apply4  7b7 ,qualified        
pharmaceutical and medical device       
manufacturing property ,for purposes of 
this section1 the term qualified        
pharmaceutical and medical device       
manufacturing property means any        
tangible property placed in service in  
the ,united ,states as part of the      
construction or expansion of property   
for the manufacture of drugs 7as defined
 in section #bja7;g7 of the ,federal    
,food1 ,drug1 and ,cosmetic ,act 7#ba   
,u4,s4,c4 #cba7;g77 or devices 7as      
defined in section #bja7;h7 of such ,act
 7#ba ,u4,s4,c4 #cba7;h77774  7c7       
,termination ,this section shall not    
apply to any property placed in service 
after ,december #ca1 #bjcj4